ChemicalBook

Olmesartan Medoxomil Impurity 4

 структура
95579-71-8
CAS №
95579-71-8
английское имя:
Olmesartan Medoxomil Impurity 4
Синонимы:
AZATMint-B;Olmesartan Medoxomil Impurity 66;4-chloro-4-methyl-5-methylene-1,3-dioxolan-2-one;4-chloro-4-methyl-5-methylene-1,3-dioxolane-2-one;4-chloro-4-methyl-5-methylidene-1,3-dioxolan-2-one;1,3-Dioxolan-2-one, 4-chloro-4-methyl-5-methylene-;4-chloro-4-methyl-5-methylene-1,3-dioxolan-2- one-NMR
CBNumber:
CB33160250
Формула:
C5H5ClO3
молекулярный вес:
148.54
MOL File:
95579-71-8.mol

Olmesartan Medoxomil Impurity 4 атрибут

растворимость: Chloroform (Sparingly), Ethyl Acetate (Slightly)
форма: Oil
цвет: Colourless to Yellow
Стабильность:: Moisture Sensitive

Заявления о рисках и безопасности

Olmesartan Medoxomil Impurity 4 химические свойства, назначение, производство

Использование

4-Chloro-4-methyl-5-methylene-1,3-dioxolan-2-one is an impurity in the synthesis of Olmesartan (O550000), An angiotensin II receptor antagonist. Used as an anti-hypertensive. Olmesartan Medoxomil Impurity 4.

Olmesartan Medoxomil Impurity 4 препаратная продукция и сырье

сырьё

препарат


Olmesartan Medoxomil Impurity 4 поставщик

Global( 43)Suppliers
поставщик телефон страна номенклатура продукции благоприятные условия
Suzhou ARTK Medchem Co., Ltd.
+86-512-68323658 +86-18168183658
China 39010 58
ShenZhen H&D Pharmaceutical Technology Co., LTD
+8618627948422
China 3389 58
sgtlifesciences pvt ltd
+8617013299288
China 12382 58
Wuhan Acumen Bio-Technology Co.,ltd 027-027-16602739303 16602739303
China 2920 58
Nanjing XiZe Biotechnology CO., Ltd. 025-66023220 0086-15250997978
China 7851 55
Cato Research Chemicals Inc. 13342851930
China 7591 58
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. 0531-58897130 15508676053
China 1932 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
China 39953 58
Nanjing Huanuo Biomedical Technology Co., Ltd 18913906212
China 6789 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 15850510341
China 3689 58
Copyright 2017 © ChemicalBook. All rights reserved